“…3,4 Nevertheless, although morbidity and mortality have improved with continuous-flow LVADs, adverse events such as stroke, bleeding, and infection still occur and can markedly decrease patients' quality of life. [5][6][7][8] Optimal outcomes require careful patient selection and an appreciation of the potential benefits and burdens of DT, especially in the setting of psychosocial concerns. The call for patient-centered heart failure is cogent in recent scientific statements that report a need for clinicians to work expertly with patients to tease out factors relevant to patients in terms of survival, quality of life, and costs.…”